Duke Cancer Institute, University Hospital — Durham, North Carolina

Duke Cancer Institute, University Hospital is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 53/100 (POOR). This profile has not yet been claimed by the site owner.

Duke Cancer Institute, University Hospital has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Melanoma.

Sponsors: Regeneron Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 53/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Institute, University Hospital?

Duke Cancer Institute, University Hospital has a Crixeo Trust Score of 53/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Institute, University Hospital conducted?

Duke Cancer Institute, University Hospital has 2 clinical trials on record, with 2 currently active. Their work covers Melanoma.

Is Duke Cancer Institute, University Hospital accredited by Crixeo Health?

Duke Cancer Institute, University Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Cancer Institute, University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.